Literature DB >> 18499864

The ligand-binding profile of HARE: hyaluronan and chondroitin sulfates A, C, and D bind to overlapping sites distinct from the sites for heparin, acetylated low-density lipoprotein, dermatan sulfate, and CS-E.

Edward N Harris1, Paul H Weigel.   

Abstract

The hyaluronic acid receptor for endocytosis (HARE)/ Stabilin-2 is the primary systemic scavenger receptor for hyaluronan (HA), the chondroitin sulfates (CS), dermatan sulfate (DS), and nonglycosaminoglycan (GAG) ligands such as acetylated low-density lipoprotein (AcLDL), pro-collagen propeptides, and advanced glycation end products. We recently discovered that HARE is also a systemic scavenger receptor for heparin (Hep) (Harris EN, Weigel JA, Weigel PH. 2008. The human hyaluronan receptor for endocytosis [HARE/Stabilin-2] is a systemic clearance receptor for heparin. J Biol Chem. 283:17341-17350). Our goal was to map the binding sites of eight different ligands within HARE. We used biotinylated GAGs and radio-iodinated streptavidin or AcLDL to assess the binding activities of ligands directly or indirectly (by competition with unlabeled ligands) in endocytosis assays using stable cell lines expressing the 315 or 190 kDa HA receptor for endocytosis (315- or 190-HARE) isoforms, and ELISA-like assays, with purified recombinant soluble 190-HARE ecto-domain. For example, Hep binding to HARE was competed by DS, CS-E, AcLDL, and dextran sulfate, but not by other CS types, HA, dextran, or heparosan. (125)I-AcLDL binding to HARE was partially competed by Hep and dextran sulfate, but not competed by HA. Two ligands, DS and CS-E, competed with both Hep and HA to some degree. Hep and HA binding or endocytosis is mutually inclusive; binding of these two GAGs occurs with functionally separate, noncompetitive, and apparently noninteracting domains. Thus, HARE binds to HA and Hep simultaneously. Although the domain(s) responsible for Hep binding remains unknown, the Link domain was required for HARE binding to HA, CS-A, CS-C, and CS-D. These results enable us to outline, for the first time, a binding activity map for multiple ligands of HARE.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18499864      PMCID: PMC2561176          DOI: 10.1093/glycob/cwn045

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  35 in total

Review 1.  Heparanases: endoglycosidases that degrade heparan sulfate proteoglycans.

Authors:  K J Bame
Journal:  Glycobiology       Date:  2001-06       Impact factor: 4.313

2.  Stabilin-1 and -2 constitute a novel family of fasciclin-like hyaluronan receptor homologues.

Authors:  Oliver Politz; Alexei Gratchev; Peter A G McCourt; Kai Schledzewski; Pierre Guillot; Sophie Johansson; Gunbjorg Svineng; Peter Franke; Christoph Kannicht; Julia Kzhyshkowska; Paola Longati; Florian W Velten; Staffan Johansson; Sergij Goerdt
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

3.  Are novel scavenger-like receptors involved in the hepatic uptake of heparin?

Authors:  Hiroaki Yuasa; Jun Watanabe
Journal:  Drug Metab Pharmacokinet       Date:  2003       Impact factor: 3.614

4.  Minimally oxidized low-density lipoprotein increases expression of scavenger receptor A, CD36, and macrosialin in resident mouse peritoneal macrophages.

Authors:  H Yoshida; O Quehenberger; N Kondratenko; S Green; D Steinberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-05       Impact factor: 8.311

5.  Expression, processing, and glycosaminoglycan binding activity of the recombinant human 315-kDa hyaluronic acid receptor for endocytosis (HARE).

Authors:  Edward N Harris; Svetlana V Kyosseva; Janet A Weigel; Paul H Weigel
Journal:  J Biol Chem       Date:  2006-12-04       Impact factor: 5.157

6.  The hyaluronan receptor for endocytosis mediates hyaluronan-dependent signal transduction via extracellular signal-regulated kinases.

Authors:  Svetlana V Kyosseva; Edward N Harris; Paul H Weigel
Journal:  J Biol Chem       Date:  2008-04-02       Impact factor: 5.157

7.  Tissue uptake of circulating hyaluronic acid. A whole body autoradiographic study.

Authors:  J R Fraser; L E Appelgren; T C Laurent
Journal:  Cell Tissue Res       Date:  1983       Impact factor: 5.249

Review 8.  Heparin and heparan sulfate: structure and function.

Authors:  Dallas L Rabenstein
Journal:  Nat Prod Rep       Date:  2002-06       Impact factor: 13.423

9.  FEEL-1, a novel scavenger receptor with in vitro bacteria-binding and angiogenesis-modulating activities.

Authors:  Hideki Adachi; Masafumi Tsujimoto
Journal:  J Biol Chem       Date:  2002-06-19       Impact factor: 5.157

10.  Characterization of the interaction between tumor necrosis factor-stimulated gene-6 and heparin: implications for the inhibition of plasmin in extracellular matrix microenvironments.

Authors:  David J Mahoney; Barbara Mulloy; Mark J Forster; Charles D Blundell; Eric Fries; Caroline M Milner; Anthony J Day
Journal:  J Biol Chem       Date:  2005-05-24       Impact factor: 5.157

View more
  40 in total

1.  Perinatal changes in mitral and aortic valve structure and composition.

Authors:  Elizabeth H Stephens; Allison D Post; Daniel R Laucirica; K Jane Grande-Allen
Journal:  Pediatr Dev Pathol       Date:  2010-06-10

2.  3-O sulfation of heparin leads to hepatotropism and longer circulatory half-life.

Authors:  Colton M Miller; Yongmei Xu; Katrina M Kudrna; Blake E Hass; Brianna M Kellar; Andrew W Egger; Jian Liu; Edward N Harris
Journal:  Thromb Res       Date:  2018-05-17       Impact factor: 3.944

3.  Chemical synthesis of a hyaluronic acid decasaccharide.

Authors:  Xiaowei Lu; Medha N Kamat; Lijun Huang; Xuefei Huang
Journal:  J Org Chem       Date:  2009-10-16       Impact factor: 4.354

4.  Inhibition of Stabilin-2 elevates circulating hyaluronic acid levels and prevents tumor metastasis.

Authors:  Yoshikazu Hirose; Eiko Saijou; Yasuyoshi Sugano; Fumitaka Takeshita; Satoshi Nishimura; Hidenori Nonaka; Yen-Rong Chen; Keisuke Sekine; Taketomo Kido; Takashi Nakamura; Shigeaki Kato; Toru Kanke; Koji Nakamura; Ryozo Nagai; Takahiro Ochiya; Atsushi Miyajima
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-27       Impact factor: 11.205

Review 5.  Receptor-Mediated Uptake of Phosphorothioate Antisense Oligonucleotides in Different Cell Types of the Liver.

Authors:  Colton M Miller; Michael Tanowitz; Aaron J Donner; Thazha P Prakash; Eric E Swayze; Edward N Harris; Punit P Seth
Journal:  Nucleic Acid Ther       Date:  2018-02-09       Impact factor: 5.486

6.  Antinociceptive activity of CC44, a biotinylated improgan congener.

Authors:  Paul Hoerbelt; Julia W Nalwalk; James G Phillips; Mark P Wentland; Zhixing Shan; Lindsay B Hough
Journal:  Eur J Pharmacol       Date:  2013-07-05       Impact factor: 4.432

7.  Hyaluronidase 1 and β-hexosaminidase have redundant functions in hyaluronan and chondroitin sulfate degradation.

Authors:  Lara Gushulak; Richard Hemming; Dianna Martin; Volkan Seyrantepe; Alexey Pshezhetsky; Barbara Triggs-Raine
Journal:  J Biol Chem       Date:  2012-03-26       Impact factor: 5.157

8.  Tissue-specific splice variants of HARE/Stabilin-2 are expressed in bone marrow, lymph node, and spleen.

Authors:  Amanda K Hare; Edward N Harris
Journal:  Biochem Biophys Res Commun       Date:  2014-11-24       Impact factor: 3.575

Review 9.  Chondroitin sulphate: a focus on osteoarthritis.

Authors:  Mamta Bishnoi; Ankit Jain; Pooja Hurkat; Sanjay K Jain
Journal:  Glycoconj J       Date:  2016-05-19       Impact factor: 2.916

10.  Rat and human HARE/stabilin-2 are clearance receptors for high- and low-molecular-weight heparins.

Authors:  Edward N Harris; Bruce A Baggenstoss; Paul H Weigel
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-09       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.